23
Feb

PTC Therapeutics is looking to get bought, Reuters‘ sources say, betting that a larger company will covet its treatment for Duchenne muscular dystrophy enough to overlook a checkered history.

…read more

Source: PTC is trawling for a buyer with its risky DMD drug, Reuters says

    

0 No comments